Skip to content

Insider · CIK 0001201221

Howard I Atkins

cfoofficerdirector

Files at DAKT (DAKTRONICS INC /SD/). First filing -, latest -.

Howard I Atkins files SEC Form 4 as CFO and director at DAKT (DAKTRONICS INC /SD/). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Howard I Atkins has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 21, 2026DAKT
DAKTRONICS INC /SD/
AGrant or award
Common Stock
+9,626$0.00$051,23920 d ago
Mar 5, 2025DAKT
DAKTRONICS INC /SD/
AGrant or award
Restricted Stock Units
+10,467$0.00$041,613Mar 7, 2025

Questions about Howard I Atkins

Answered from the filings on this page, as of the latest one.

Is Howard I Atkins buying or selling?

Howard I Atkins has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Howard I Atkins's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Howard I Atkins has 0.

Where does Howard I Atkins file Form 4?

Howard I Atkins has filed Form 4 at DAKT (DAKTRONICS INC /SD/) as CFO and CTO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.